This edition provides data on Medicaid prescription drug usage and costs and trends from 2013 to 2015. Each data table shows national totals and subtotals for three groups of states: non-expansion states, initial Medicaid expansion states (those implementing Medicaid expansion in January 2014), and subsequent expansion states. The tables show all Medicaid-paid pharmacy volume, including prescriptions paid by Medicaid MCOs and those paid in the Medicaid fee-for-service setting. Tables differentiate pre-rebate and post-rebate spending.
- Keywords: Expansion Expenditures Medicaid Prescription Drugs
The April 2015 edition presents recent nationwide and state-level data on Sovalidi usage. These slides also convey recent usage of a related Hepatitis C medication (Harvoni) as well as a specialty pharmacy drug, Kalydeco, in a completely different clinical area for comparison purposes.
- Keywords: Medicaid Prescription Drugs
This edition provides updated COVID-19 data on five states where the per capita rate of infection has been highest – Louisiana, Massachusetts, New Jersey, New York, and Washington. Confirmed cases and deaths are at the county level. Ten “hot spot” counties, nine of which are in New York and the tenth in Louisiana, accounted for 40% of all confirmed cases in the USA as of March 25
- Keywords: COVID-19
This edition of our 5 Slide Series examines excess deaths at the state level during the pandemic. Taking the difference of average monthly deaths during the pandemic and a pre-pandemic average, we find that states in the South and Southwest have experienced the largest percentage increase in deaths above normal. In addition, despite experiencing a particularly deadly first wave in the spring of 2020, New England states have collectively experienced the lowest number of excess deaths per capita; we find that 5 of the 11 states with the least number of excess deaths per capita are in this region. Second, we estimate excess deaths among different cohorts, including age, race/ethnicity, and cause of death. For age, we find that the 25–44 age bracket experienced the sharpest percentage increase in all-cause observed deaths in 2020 and 2021 compared to its 2015-2019 historical average. For race, we find that Hispanics experienced the sharpest percentage increase in all-cause observed deaths in 2020 and 2021, followed by American Indians/Alaska Natives and Asians. Lastly, we use cause of death data to confirm that deaths from Alzheimer’s disease/dementia increased the most during the pandemic, followed by deaths from circulatory disease. This latter finding dovetails with our February 4th edition, which showed that COVID deaths have likely been substantially undercounted. The spike in Alzheimer’s deaths could involve COVID death categorization dynamics.
- Keywords: COVID-19
This edition tabulates COVID death and case progression among the 25 most populous U.S. counties (which collectively are home to 21% of the country’s residents). We’ve also update vaccination data by state – as of February 10, all states have administered one or more doses of the vaccine to at least 10% of their population.
- Keywords: COVID-19